Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3
Monday, June 24, 2019Arrowhead Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has granted orphan drug designation to AROAPOC for the treatment of familial chylomicronemia syndrome FCS There is no currently available therapy in the US that can...
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
Friday, June 21, 2019WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced that it planned to expand the new stateoftheart integrated biologics conjugat...
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
Thursday, June 20, 2019Gilead Sciences Inc and Nurix Therapeutics Inc a company discovering drugs that harness the bodys natural process to control protein levels today announced a global strategic collaboration to discover develop and commercialize a pipeline of innovativ...
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies
Thursday, June 20, 2019Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development of novel products for serious rare and ultrarare genetic diseases and Arcturus Therapeutics Holdings Inc a leading messenger RNA medicines company today announced th...
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing
Wednesday, June 19, 2019ThermoGenesis Corp a wholly owned subsidiary of Cesca Therapeutics Nasdaq KOOL and a market leader in automated cellular processing today announced that it has received Health Canada approval of its nextgeneration AXPII system for cord blood processi...
Premier Inc. Partners with Pensiamo Inc. and UPMC to Launch AI-Powered Pharmaceutical Supply Chain Solution
Wednesday, June 19, 2019Premier Inc a healthcare improvement company and Pensiamo Inc a cognitive supply chain company have partnered to launch a new pharmaceutical supply chain solution that was codeveloped with UPMC a worldrenowned healthcare provider and insurer
Halo Labs to Expand Globally and Acquire Bophelo Bioscience
Tuesday, June 18, 2019Halo Labs Inc is pleased to announce that it has entered into a nonbinding letter of intent LOI for the proposed acquisition of Bophelo Bioscience Wellness Pty Ltd Bophelo the Transaction The Transaction is expected to strengthen the Companys positi...
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
Tuesday, June 18, 2019CASI Pharmaceuticals Inc a US biopharmaceutical company that is focusing on developing and accelerating the launch of innovative therapeutics and pharmaceutical products in China the US and throughout the world announces the signing of a license agre...
Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories
Saturday, June 15, 2019Theravance Biopharma Ireland Limited a subsidiary of Theravance Biopharma Inc and Mylan NV today announced the expansion of the companies current development and commercialization agreement for nebulized revefenacin to include China and certain adja...
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
Friday, June 14, 2019Eton Pharmaceuticals Inc a specialty pharmaceutical company focused on developing and commercializing innovative drug products today announced that the Company has entered into an agreement with Aucta Pharmaceuticals Inc to acquire US marketing righ...
